- Correspondences Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
- Moon Haeng Hur, Yoon Jun Kim
- Clin Mol Hepatol. 2025;31(1):e93-e95.
- Original Articles Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
- Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
- Clin Mol Hepatol. 2024;30(3):500-514.
- Editorials Toward hepatitis C virus elimination using artificial intelligence
- Moon Haeng Hur, Jeong-Hoon Lee
- Clin Mol Hepatol. 2024;30(2):147-149.
- Original Articles Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
- Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim
- Clin Mol Hepatol. 2023;29(3):763-778.
- Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
- Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
- Clin Mol Hepatol. 2023;29(3):794-809.
- Editorials The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
- Moon Haeng Hur, Jeong-Hoon Lee
- Clin Mol Hepatol. 2023;29(2):363-366.